Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

REKHI P VARGHESE

Allopathic & Osteopathic Physicians Internal Medicine Interventional Cardiology

NPI
1659347243
CMS profile
1207243
Location
WASHINGTON, PA

General Payments · PY2018–2024

$8,551.54

  • Reported across 241 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$738.36

13 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $738.36 13

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Medtronic, Inc. $334.07 4
Edwards Lifesciences Corporation $234.25 5
ABIOMED $114.36 1
Abbott Laboratories $39.29 2
BOSTON SCIENTIFIC CORPORATION $16.39 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,948.74 69
PY2019 $1,412.57 62
PY2020 $1,140.78 25
PY2021 $710.24 23
PY2022 $2,264.08 37
PY2023 $336.77 12
PY2024 $738.36 13

Payment records · PY2024 (13)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $20.75 05/03/2024 Food and Beverage Undisputed 01/23/2026 1125173487 CMS
Abbott Laboratories $18.54 07/30/2024 Food and Beverage Undisputed 01/23/2026 1125173489 CMS
ABIOMED $114.36 10/21/2024 Food and Beverage Undisputed 01/23/2026 1142201609 CMS
Boston Scientific Corporation $16.39 07/10/2024 Food and Beverage Undisputed 01/23/2026 1092305687 CMS
Edwards Lifesciences Corporation $19.55 02/07/2024 Food and Beverage Undisputed 01/23/2026 1138779193 CMS
Edwards Lifesciences Corporation $19.83 08/21/2024 Food and Beverage Undisputed 01/23/2026 1138779271 CMS
Edwards Lifesciences Corporation $10.86 10/24/2024 Food and Beverage Undisputed 01/23/2026 1138779289 CMS
Edwards Lifesciences Corporation $160.76 11/06/2024 Food and Beverage Undisputed 01/23/2026 1138779293 CMS
Edwards Lifesciences Corporation $23.25 12/18/2024 Food and Beverage Undisputed 01/23/2026 1138779417 CMS
Medtronic, Inc. $22.91 03/20/2024 Food and Beverage Undisputed 01/23/2026 1119419071 CMS
Medtronic, Inc. $144.41 04/25/2024 Food and Beverage Undisputed 01/23/2026 1119419073 CMS
Medtronic, Inc. $141.92 06/27/2024 Food and Beverage Undisputed 01/23/2026 1119419075 CMS
Medtronic, Inc. $24.83 10/28/2024 Food and Beverage Undisputed 01/23/2026 1119419077 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.